CHELSEA THERAPEUTICS INTERNATIONAL, LTD.: 10-Q filed 2011-07-27
What CHELSEA THERAPEUTICS INTERNATIONAL, LTD. reported in its quarterly report filed 2011-07-27 (fiscal Q2 2011): 25 published measures, 74 facts as tagged in accession 0001193125-11-198939.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-07-27
- Fiscal period
- fiscal Q2 2011
- Accession
- 0001193125-11-198939 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHELSEA THERAPEUTICS INTERNATIONAL, LTD. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 68,249,771 | USD | |
| At 2010-12-31 | 48,373,908 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 12,682,491 | USD | |
| At 2010-12-31 | 13,186,144 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 55,567,280 | USD | |
| At 2010-12-31 | 35,187,764 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 10,966,999 | USD | |
| At 2010-12-31 | 47,593,055 | USD | |
| At 2010-06-30 | 23,048,712 | USD | |
| At 2009-12-31 | 22,294,649 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -13,271,387 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -27,139,593 | USD | 181 |
| 2002-04-03 to 2011-06-30 | -160,012,930 | USD | 3376 |
| 2010-04-01 to 2010-06-30 | -9,924,325 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -16,156,334 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -26,512,428 | USD | 181 |
| 2002-04-03 to 2011-06-30 | -139,074,341 | USD | 3376 |
| 2010-01-01 to 2010-06-30 | -16,018,522 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 140,516 | USD | 181 |
| 2002-04-03 to 2011-06-30 | 627,521 | USD | 3376 |
| 2010-01-01 to 2010-06-30 | 13,181 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 46,172,107 | USD | 181 |
| 2002-04-03 to 2011-06-30 | 206,848,499 | USD | 3376 |
| 2010-01-01 to 2010-06-30 | 5,296,911 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -56,285,735 | USD | 181 |
| 2002-04-03 to 2011-06-30 | -56,807,158 | USD | 3376 |
| 2010-01-01 to 2010-06-30 | 11,475,674 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 260,892 | USD | |
| At 2010-12-31 | 180,021 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 1,347,002 | USD | 181 |
| 2002-04-03 to 2011-06-30 | 7,688,917 | USD | 3376 |
| 2010-01-01 to 2010-06-30 | 1,009,454 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -13,322,703 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -27,225,491 | USD | 181 |
| 2002-04-03 to 2011-06-30 | -164,620,171 | USD | 3376 |
| 2010-04-01 to 2010-06-30 | -9,990,867 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -16,257,474 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 67,950,784 | USD | |
| At 2010-12-31 | 48,155,792 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2002-04-03 to 2011-06-30 | 258,348 | USD | 3376 |
| 2010-04-01 to 2010-06-30 | 35,381 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 68,334 | USD | 181 |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 2,456,685 | USD | |
| At 2010-12-31 | 2,288,241 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 13,322,703 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 27,225,491 | USD | 181 |
| 2002-04-03 to 2011-06-30 | 164,620,171 | USD | 3376 |
| 2010-04-01 to 2010-06-30 | 9,990,867 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 16,257,474 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 10,681,032 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 22,139,974 | USD | 181 |
| 2002-04-03 to 2011-06-30 | 130,630,259 | USD | 3376 |
| 2010-04-01 to 2010-06-30 | 8,394,276 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 13,274,749 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 61,847,700 | shares | |
| At 2010-12-31 | 49,790,975 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 215,574,023 | USD | |
| At 2010-12-31 | 168,056,121 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 38,095 | USD | |
| At 2010-12-31 | 38,095 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 8,698,397 | USD | |
| At 2010-12-31 | 8,950,469 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 477,973 | USD | |
| At 2010-12-31 | 246,374 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 1,317,454 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 2,650,170 | USD | 181 |
| 2002-04-03 to 2011-06-30 | 22,597,697 | USD | 3376 |
| 2010-04-01 to 2010-06-30 | 1,088,171 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 2,063,758 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 59,644 | USD | 181 |
| 2002-04-03 to 2011-06-30 | 365,158 | USD | 3376 |
| 2010-01-01 to 2010-06-30 | 34,595 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2002-04-03 to 2011-06-30 | 224,328 | USD | 3376 |
| 2010-01-01 to 2010-06-30 | 68,334 | USD | 181 |
Inspect the source
- Entity
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. / CIK 0001333763
- Captured
- SEC response SHA-256
354bb9243ece9eacb7fe265090cbbf659edca4a013cc87523793af082dfdb51c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001333763.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))